Despite medical marijuana programs being passed or enacted in a supermajority of states, federal policy currently prohibits VA-affiliated doctors from even recommending medical cannabis to veterans in those states where such use is legal — thus forcing military veterans to seek the advice of a private, out-of-network physician.
In a letter addressed to Rep. Eleanor Holmes-Norton, the agency says that it will continue to enforce policies that involve the “termination of the tenancy of any household” in instances where a tenant is found to have engaged in the use of a controlled substance while on the premises — “including [the use of] state legalized medical marijuana.”
“Should President Biden wish to acknowledge the political, economic, and moral realities surrounding cannabis policy, and fulfill the promises he made on the campaign trail, this report lays out a clear roadmap for how to do so.”
Scientists reported: “Our results clearly demonstrate that NIDA cannabis samples are substantially genetically different from most commercially available drug-type strains and share a genetic affinity with hemp samples in several of the analyses.”
In the newly released annual spending packages by the Senate Appropriations Committee, cannabis policy is scantly mentioned yet by omission, it could advance a critical element of reform that has long been pushed for by NORML and other allies.
Members of the House Judiciary Committee just advanced the HR 3617: The Marijuana, Opportunity, Reinvestment, and Expungement (MORE) Act of 2021. The Act repeals the long-standing federal prohibition of marijuana by removing it from the Controlled Substances Act — thereby ending the existing state/federal conflict in cannabis policies and providing state governments with greater authority to regulate marijuana-related activities, including retail sales.
For the second time in US history legislation to repeal the failed, unscientific, and racist policy of federal marijuana prohibition has passed the powerful House Judiciary Committee.